-

ONESTREAM SHAREHOLDER NOTE: Kaskela Law Firm Announces Investigation of OneStream, Inc. Shareholder Buyout Proposal and Encourages Investors to Contact the Firm – OS

PHILADELPHIA--(BUSINESS WIRE)--On behalf of OneStream, Inc. (NASDAQ: OS) investors, Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of OneStream’s shareholders to determine whether the buyout price provides investors with a high enough buyout price for their OneStream shares.

The investigation seeks to determine whether investors will be receiving a sufficiently high cash price for their shares, and whether the company’s representatives breached their fiduciary duties to investors in agreeing to the buyout price.

Share

Click here to request additional information: https://kaskelalaw.com/case/onestream/

On January 6, 2026, OneStream announced that it had agreed to be acquired by private equity firm Hg at a price of $24.00 per share in cash. Following the closing of the proposed transaction, OneStream shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether investors will be receiving a sufficiently high cash price for their shares, and whether the company’s representatives breached their fiduciary duties to investors in agreeing to the buyout price. Notably, at the time the proposed transaction was announced, several stock analysts were maintaining a price target for OneStream’s shares of $27.00 per share.

If you are a OneStream investor and would like to learn more about our investigation, please click here to fill out our online form, or contact lead investigative attorney Adrienne Bell, Esq. at (484) 229 – 0750 or by email at abell@kaskelalaw.com. You can also click on the following link or paste it into your browser to learn more about the investigation and your legal rights and options:

https://kaskelalaw.com/case/onestream/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

Industry:

KASKELA LAW LLC

NASDAQ:OS
Release Versions
English

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

More News From KASKELA LAW LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom